Shangpin China signed a contract with Shanghai Aoneng Biology to build a digital official website upgrade

Shangpin China signed a contract with Shanghai Aoneng Biotechnology Co., Ltd. to build a digital official website upgrade, promote the digital transformation of biotechnology, and create a new brand image.

Biotechnology Website construction It is not only necessary to highlight the professional ability of the company, but also need to have strong communication value. This can not only bring traffic and turn it into customer leads, but also promote customer decisions. According to data, compared with advertising, many company managers prefer to search for companies based on website and article content.

Shanghai Aoneng Biotechnology Co., Ltd. focuses on the field of primary cells, provides hundreds of primary cell products of different species, and provides preclinical efficacy evaluation services for drug development based on primary immune cells.

The in vivo technical service team is mainly specialized in the in vivo efficacy evaluation based on PBMC humanized mice and HSC humanized mice. At present, it has provided in vivo efficacy services for many domestic pharmaceutical enterprises. The evaluation targets include PD1, PDL-1, CTLA4, double antibody, EGFR, etc. The tumor models evaluated include MDA-MB-231, HCC827, H292, A-375, Raji, U87MG, etc.

In vitro technical service team is mainly good at in vitro efficacy evaluation of macromolecular drugs, such as ADCC, MLR, T-cell killing, T-cell activation, etc.

Aoneng Biology is committed to becoming an international level, domestic leading primary cell supply platform, and an integrated platform for in vivo and in vitro drug efficacy services based on primary immune cells.